[
  {
    "symbol": "MEDP",
    "price": 229.09,
    "beta": 1.416901,
    "volAvg": 387864,
    "mktCap": 6987038819,
    "lastDiv": 0,
    "range": "141.3-241.475",
    "changes": 6.08,
    "companyName": "Medpace Holdings, Inc.",
    "currency": "USD",
    "cik": "0001668397",
    "isin": "US58506Q1094",
    "cusip": "58506Q109",
    "exchange": "NASDAQ Global Select",
    "exchangeShortName": "NASDAQ",
    "industry": "Diagnostics & Research",
    "website": "https://www.medpace.com",
    "description": "Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.",
    "ceo": "Dr. August James Troendle M.D.",
    "sector": "Healthcare",
    "country": "US",
    "fullTimeEmployees": "5400",
    "phone": "513 579 9911",
    "address": "5375 Medpace Way",
    "city": "Cincinnati",
    "state": "OH",
    "zip": "45227",
    "dcfDiff": 7.45359,
    "dcf": 231.134,
    "image": "https://financialmodelingprep.com/image-stock/MEDP.png",
    "ipoDate": "2016-08-11",
    "defaultImage": false,
    "isEtf": false,
    "isActivelyTrading": true,
    "isAdr": false,
    "isFund": false
  }
]